Page 52 - The SA Journal Diabetes & Vascular Disease Volume 9 No 4 (November 2012)

R39,00 SEP excl. VAT
SR 30 mg D y n a G l i c l a z i d e
s u s t a i n e d c o n t r o l
Dyna Gliclazide SR 30 mg . Each modified release tablet contains 30 mg gliclazide. Reg. No.: S3 42/21.2/0249.
For full prescribing information, refer to the package insert approved by the Medicines Regulatory Authority.
1. Crepaldi G and Fioretto P. Gliclazide modified release: Its place in the therapeutic armamentarium. Metabolism. 2000;49(10) supplement 2:21-25.
2. McGavin JK, Perry CM and Goa KL. Gliclazide modified release. Drugs. 2002;62(9):1357-1364.
3. Data on file.
4. Department of Health websitehttp://www.doh.gov.za– Accessed on 01/04/2012.
5. http://en.wikipedia.org/wiki/hummingbird.
DesignedFOR SUSTAINED CONTROL